Diabetic Macular Edema (DME) Recruiting Phase 4 Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03832179Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to PhacoemulsificationTreatment